Viruses 2010, 2, 2037-2077; doi:10.3390/v2092037 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis Priya Kannian 1,2 and Patrick L. Green 1,2,3,4,* 1 Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; E-Mail:
[email protected] 2 Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA 3 Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA 4 Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA * Author to whom correspondence should be addressed; E-Mail:
[email protected]; Tel.: +1 614-688-4899; Fax: +1 614-292-6473. Received: 7 July 2010; in revised form: 25 August 2010 / Accepted: 15 September 2010 / Published: 24 September 2010 Abstract: Human T lymphotropic viruses (HTLVs) are complex deltaretroviruses that do not contain a proto-oncogene in their genome, yet are capable of transforming primary T lymphocytes both in vitro and in vivo. There are four known strains of HTLV including HTLV type 1 (HTLV-1), HTLV-2, HTLV-3 and HTLV-4. HTLV-1 is primarily associated with adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-2 is rarely pathogenic and is sporadically associated with neurological disorders. There have been no diseases associated with HTLV-3 or HTLV-4 to date. Due to the difference in the disease manifestation between HTLV-1 and HTLV-2, a clear understanding of their individual pathobiologies and the role of various viral proteins in transformation should provide insights into better prognosis and prevention strategies.